"10.1371_journal.ppat.1005297","plos pathogens","2015-11-20T00:00:00Z","Margaret A Scull; William M Schneider; Brenna R Flatley; Robert Hayden; Canny Fung; Christopher T Jones; Marieke van de Belt; François Penin; Charles M Rice","Center for the Study of Hepatitis C, The Rockefeller University, New York, New York, United States of America; Bases Moléculaires et Structurales des Systèmes Infectieux, IBCP, Labex Ecofect, Université Lyon 1, France; CNRS, UMR 5086, Lyon, France","Conceived and designed the experiments: MAS CTJ FP CMR. Performed the experiments: MAS WMS BRF RH CF FP. Analyzed the data: MAS FP. Contributed reagents/materials/analysis tools: CTJ MvdB WMS. Wrote the paper: MAS FP.","The authors declare the following conflicts of interest, which are managed under the Rockefeller Universitys policy: CMR has equity in Apath, LLC, which holds commercial licenses for the Huh-7.5 cell line and HCV cell culture system. This does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.","2015","11","Margaret A Scull","MAS",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
